Machine Learning Viz.ai Announces Agreement with Bristol Myers Squibb to Enable Earlier Detection and Management of… Business Wire Mar 4, 2023 Viz.ai has submitted a de novo classification request to the FDA for a new AI algorithm intended to identify and triage patients suspected with…
Machine Learning BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies AIT News Desk Jul 21, 2022 Capital will advance BigHat’s internal pipeline of therapeutics to patients, expand platform capacity 10-fold, and accelerate strategic…
Analytics Bristol Myers Squibb Selects ZS To Support Global Commercialization and Analytics Capabilities AIT News Desk Jan 11, 2022 Global professional services firm ZS has been selected by leading biopharmaceutical company Bristol Myers Squibb (BMS) to support its worldwide…